The increasing prevalence of knee OA heightens the urgency of the search for effective therapies.
However, the degree to which biosimilars will drive down the cost of biologic therapy remains to be seen.
British investigators take a long-range view of tumor necrosis factor inhibitors in patients with psoriatic arthritis.
An expanded role for MRI and 2 recently approved treatment options.
Good management of rheumatoid arthritis may also prevent serious infection, myocardial infarction, and even death related to comorbid disease.
Menopause, obesity, and bacterial infection all have a negative impact on RA, according to 3 recent studies.
The EULAR definition of arthralgia suspicious for progression to RA was recently validated.
What does compensation for rheumatologists look like these days? Would you choose rheumatology all over again? Here: key highlights from the Medscape Rheumatologist Compensation Report.
Post-treatment Lyme disease syndrome is a real disorder with real symptoms, say researchers.
An online tool for juvenile arthritis, guidelines on childhood lupus, and good news about the response to treatment for ANCA-associated vasculitis
Abnormalities in the proportion of anti-inflammatory strains may represent a potential target for therapy.
Norwegian researchers looked at the long-term prevalence of inflammatory back disorders in patients with IBD—and identified a predisposing factor.
Product may be contaminated with Salmonella.
Are you up-to-date on the latest EULAR/ACR classification criteria?
Highlights of 5 topline news stories from the FDA, CDC, and American College of Rheumatology—with real-world implications for primary care practice.